3-Oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diyl diacetate

Catalog No. :
ACGDIQ930
CAS No. :
596-09-8
Molecular Formula :
C24H16O7
Molecular Weight :
416.39

IUPAC Name:3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diyl diacetate

3-Oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diyl diacetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$92.00Login to see priceIn stockIn stock
100g98%$361.00Login to see priceIn stockIn stock
500g98%$1444.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diyl diacetate
IUPAC Name3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-3',6'-diyl diacetate
MDL No.MFCD00005062
Molecular FormulaC24H16O7
Molecular Weight416.39
SMILESO=C1OC2(C3=C(OC4=C2C=CC(OC(C)=O)=C4)C=C(OC(C)=O)C=C3)C5=C1C=CC=C5
InChI KeyCHADEQDQBURGHL-UHFFFAOYSA-N
SynonymFDA | Diacetil-Fluoresceina | acetic acid (6''-acetoxy-3-keto-spiro[phthalan-1,9''-xanthene]-3''-yl) ester | (6''-acetyloxy-3-oxospiro[2-benzofuran-1,9''-xanthene]-3''-yl) acetate | (6'-acetyloxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-3'-yl) acetate | NSC
CAS No.596-09-8
PubChem CID65047

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACGDIQ930 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBICH106 route compound structure diagram
    ACBICH106518-47-8
  2. Then
  3. ACGDIQ930 route product structure diagram
    ACGDIQ930596-09-8 In Stock
Inquiry

2. ACGDIQ930 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLABC236 route compound structure diagram
    ACLABC236124387-19-5 In Stock
  2. Then
  3. ACGDIQ930 route product structure diagram
    ACGDIQ930596-09-8 In Stock
Inquiry

Comments (0)